Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-25442

Xtr Wt + sox17a MO + sox17b.1/b.2 MO, Mukherjee S et al. (2020)

Experiment + Assay: Xtr Wt + sox17a MO + sox17b.1/b.2 MO + NF35/36 (in situ hybridization)
Background: Xtr.NigerianNasco
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection sox17b.1/b.2 MO1 sox17b.2
sox17b.1
 NF stage 2- blastomere
morpholino injection sox17a MO5 sox17a
 NF stage 2- blastomere
Conditions:
Assay Type Assay Stages Antibody
in situ hybridization NF stage 35 and 36  
Expression Phenotypes (11):
decreased amount isl1 expression in eye
decreased amount isl1 expression in intestine
decreased amount isl1 expression in pharyngeal region
decreased amount isl1 expression in pharynx
decreased amount isl1 expression in profundus ganglion
decreased amount nr1h5 expression in liver
decreased amount nr1h5 expression in pharyngeal region
decreased amount osr1 expression in cement gland
decreased amount osr1 expression in intestine
decreased amount osr1 expression in lung
decreased amount osr1 expression in stomach
Source: Fig.1.S1.C
Article: XB-ART-57340, PubMed